AAIPharma Services (Wilmington, North Carolina, USA) has opened a technology centre at its headquarters.
AAIPharma Services (Wilmington, North Carolina, USA) has opened a technology centre at its headquarters. The centre is part of a $15 million capital expansion programme, with plans in the works to expand its manufacturing centres in both Charleston, South Carolina, USA, and Wilmington.
The centre was designed with flexible workstations to meet the changing requirements for developing and testing pharmaceutical and biopharmaceutical products. The centre has also received a batch of new UHPLC, HPLC, GC–MS and LC–MS–MS instruments.
Patrick Walsh, CEO of AAIPharma, commented, “We’ve designed this technology centre as an adaptable laboratory concept that gives us the flexibility to meet our clients’ increasingly diverse needs. We remain committed to investing in our employees’ infrastructure and our region as we project continued and sustainable business growth.”
For more information please visit ref="http://www.aaipharma.com">www.aaipharma.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.